Literature DB >> 10028450

The utility of ANCA and ASCA in inflammatory bowel disease.

S R Targan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10028450     DOI： 10.1097/00054725-199902000-00008

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  10 in total

Review 1.  Serologic testing in inflammatory bowel disease: its value in indeterminate colitis.

Authors:  K A Papadakis; S R Targan
Journal:  Curr Gastroenterol Rep       Date:  1999-12

Review 2.  Indeterminate colitis.

Authors:  M Guindi; R H Riddell
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

Review 3.  Ampullary stenosis with biliary obstruction in duodenal Crohn's disease: a case report and review of the literature.

Authors:  Kenny Yung; Jaime Oviedo; Francis A Farraye; James M Becker; Charles W Andrews; David Lichtenstein
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

4.  Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease.

Authors:  Frauke Degenhardt; Andrea Dirmeier; Rocio Lopez; Sylvia Lang; Claudia Kunst; Dirk Roggenbuck; Dirk Reinhold; Silke Szymczak; Gerhard Rogler; Frank Klebl; Andre Franke; Florian Rieder
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

5.  Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.

Authors:  Anupa Kamat; Petronela Ancuta; Richard S Blumberg; Dana Gabuzda
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

6.  A case presentation of a pulmonary complication of ulcerative colitis.

Authors:  Ambika Talwar; Heinke Kunst; Theodore Ngatchu; Simon Trotter
Journal:  BMJ Case Rep       Date:  2013-01-02

7.  Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients.

Authors:  Ira Shafran; Christopher Piromalli; Jonathan W Decker; Javier Sandoval; Saleh A Naser; Fouad A K El-Zaatari
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

Review 8.  Update in pediatric inflammatory bowel disease.

Authors:  Shervin Rabizadeh; Marla Dubinsky
Journal:  Rheum Dis Clin North Am       Date:  2013-07-17       Impact factor: 2.670

9.  Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis.

Authors:  Florian Rieder; Rocio Lopez; Andre Franke; Alexandra Wolf; Stephan Schleder; Andrea Dirmeier; Anja Schirbel; Philip Rosenstiel; Nir Dotan; Stefan Schreiber; Gerhard Rogler; Frank Klebl
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

10.  Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease.

Authors:  Juan J Estruch; Derren Barken; Nicole Bennett; Donald K Krawiec; Gregory K Ogilvie; Barbara E Powers; Benjamin J Polansky; Michael T Sueda
Journal:  J Vet Intern Med       Date:  2020-04-13       Impact factor: 3.333
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.